Holen Sie sich die Stockscreener-App
2.5396
0.38%
0.0096
Handel nachbörslich:
2.56
0.0204
+0.80%
Schlusskurs vom Vortag:
$2.53
Offen:
$2.41
24-Stunden-Volumen:
72,823
Relative Volume:
0.44
Marktkapitalisierung:
$17.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.65M
KGV:
-0.5707
EPS:
-4.45
Netto-Cashflow:
$-20.83M
1W Leistung:
+16.50%
1M Leistung:
+16.50%
6M Leistung:
+62.00%
1J Leistung:
-1.57%
1-Tages-Spanne:
$2.41
$2.60
1-Wochen-Bereich:
$2.2378
$3.2899
52-Wochen-Spanne:
$1.15
$3.2899
Minerva Neurosciences Inc Stock (NERV) Company Profile
Firmenname
Minerva Neurosciences Inc
Sektor
Branche
Telefon
617-600-7373
Adresse
1601 TRAPELO ROAD, WALTHAM, MA
Vergleichen Sie NERV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
2.5396 | 17.69M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-14 | Eingeleitet | BTIG Research | Buy |
| 2019-10-02 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-09-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-09-18 | Eingeleitet | William Blair | Outperform |
| 2019-05-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-09-01 | Eingeleitet | Citigroup | Buy |
| 2017-03-06 | Fortgesetzt | Jefferies | Buy |
| 2016-05-12 | Fortgesetzt | Jefferies | Buy |
Alle ansehen
Minerva Neurosciences Inc Aktie (NERV) Neueste Nachrichten
How buybacks impact Minerva Neurosciences Inc. stock valueTrade Entry Report & High Conviction Trade Alerts - newser.com
What to do if you’re stuck in Minerva Neurosciences Inc.Fed Meeting & Risk Managed Investment Strategies - newser.com
Can technical indicators confirm Minerva Neurosciences Inc.’s reversalJuly 2025 Update & AI Powered Market Entry Strategies - newser.com
Is Minerva Neurosciences Inc. stock vulnerable to regulatory risksJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Is Minerva Neurosciences Inc. stock overvalued by current metricsJuly 2025 Retail & Fast Entry High Yield Tips - newser.com
Will Minerva Neurosciences Inc. (4MNA) stock outperform global peersPortfolio Profit Report & Short-Term Trading Opportunity Alerts - newser.com
How to escape a deep drawdown in Minerva Neurosciences Inc.Price Action & Stock Market Timing Techniques - newser.com
Chart based exit strategy for Minerva Neurosciences Inc.Market Growth Summary & AI Forecast for Swing Trade Picks - newser.com
Minerva Neurosciences Inc. recovery potential after sell offWeekly Loss Report & Risk Adjusted Swing Trade Ideas - newser.com
Automated trading signals detected on Minerva Neurosciences Inc.July 2025 Decliners & High Return Stock Watch Alerts - newser.com
Reversal indicators forming on Minerva Neurosciences Inc. stockAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Is Minerva Neurosciences Inc. a candidate for recovery playMarket Performance Summary & Weekly Setup with High ROI Potential - newser.com
Key resistance and support levels for Minerva Neurosciences Inc.2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
Parkinson Disease Pipeline Drugs 2025 Report: Emerging Drugs, Innovative Therapies, Clinical Trial Updates, and Top Companies - Barchart.com
Would You Accumulate or Wait on JTEKT India Limited (JTEKTINDIA)Earnings Per Share Trends & Free Explosive Trading Growth - earlytimes.in
Is Minerva Neurosciences Inc. stock dividend yield sustainableTrend Reversal & Risk Managed Trade Strategies - newser.com
What analysts say about Minerva Neurosciences Inc 4MNA stockMarket Correction Analysis & Outperform the Market with Aggressive Picks - earlytimes.in
Chart based analysis of Minerva Neurosciences Inc. trendsSell Signal & High Win Rate Trade Tips - newser.com
Is it time to cut losses on Minerva Neurosciences Inc.July 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
ProShares Trust ProShares UltraShort MSCI Japan Stock Analysis and ForecastStock Market Trends & Small Investment Growth Tips - earlytimes.in
What drives CopAur Minerals Inc RFC4 stock priceInsider Buying Signals & Low Risk Trading Plans - earlytimes.in
What analysts say about Shutterstock Inc stockRetail Trading Trends & Budget Friendly Growth - earlytimes.in
Does Minerva Neurosciences Inc. qualify in momentum factor screeningMarket Trend Report & Reliable Entry Point Alerts - newser.com
What drives Minerva Neurosciences Inc stock priceSell Signals and Alerts & Tap Into the Fastest-Growing Companies - earlytimes.in
Is Farmer Bros. Co. stock a buy on dipsTrade Entry Report & Verified Entry Point Signals - newser.com
Minerva Neurosciences Inc Stock Analysis and ForecastPrice Support Zones & Free Tap Rapid Wealth - earlytimes.in
What market sentiment indicators show for Algernon Pharmaceuticals Inc. (AGW0) stock2025 Geopolitical Influence & Weekly Breakout Watchlists - newser.com
Best data tools to analyze OSR Holdings Inc. stockJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - newser.com
How RSPH stock behaves in tightening cyclesWeekly Gains Report & AI Powered Market Trend Analysis - newser.com
Is Dimensional ETF Trust Dimensional World stock a buy during volatile marketsPortfolio Update Summary & AI Powered Trade Plan Recommendations - newser.com
Finanzdaten der Minerva Neurosciences Inc-Aktie (NERV)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):